The Latest Breaking News from Protein

Aim to have your breakfast contain protein, carbohydrates — focusing on fiber — and a reasonable amount of fat.

Machine learning and other artificial intelligence (AI) methods have had immense success with scientific and technical tasks such as predicting how protein molecules fold and recognising faces in a crowd. However, the application of these methods to the humanities are yet to be fully explored.

A team of international scientists has discovered a way to produce higher quality wheat, which could increase protein content by up to 25 per cent.

Gradually replacing 20 percent of global beef and lamb consumption with meat-textured proteins also known as ‘Faux Beef’ could cut agriculture-related CO2 emissions and deforestation in half by 2050, a new study by the Potsdam Institute for Climate Impact Research (PIK) reported. Faux meat derived by culturing microbial or fungi-based…

Muscles are not created equal. What that means, is your neighbor may be able to develop a six-pack more quickly and easily than you, even if you began a workout journey weeks ago. Genetics, among other things like your current fitness level and body fat percentage, play a huge role in how…

The meat-free sticks are made from pea and wheat protein

Chickpea pasta is trendy because it's higher in protein and fiber, but that doesn't necessarily mean everyone should abandon regular pasta.

Valerie T writes: "I am emailing you on the request of my dad who is 88 and has several health issues. He read what you had to say about beef and fish. He wanted to know about pork and the pros and cons of it.

BridgeBio Pharma Inc (NASDAQ:BBIO) estimates between $23 million to $25 million in restructuring-related costs, including write-offs of long-lived assets, severance and employee-related costs, and exit and other related costs. “The restructuring initiative included, among other components, consolidation and rationalization of facilities, reprioritization of development programs, and the reduction of our workforce,” the company…

Turning Point Therapeutics Inc (NASDAQ:TPTX) entered into an exclusive license agreement with LaNova Medicines Limited to develop and commercialize LM-302, in the U.S. and the rest of the world, excluding Greater China and South Korea.  LM-302 is a novel antibody-drug conjugate (ADC) targeting Claudin18.2, a protein expressed in many gastrointestinal cancers, including gastric, gastroesophageal junction,…

Test your Science quotient with this quiz